Britannia's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Britannia Industries for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)4,4321.24,06410.364,485
Total Expenses (₹crs.)3,773-2.333,4456.973,685
Net Profit (₹crs.)49019.5945528.79586
Margin (%)11.062.0111.201.8713.07

 

REVENUE: 
Britannia reported a total income of ₹4,485 crores in the second quarter of fiscal year 2024, reflecting a steady increase sequentially, when the revenue was ₹4,064 crores. While the quarter-on-quarter growth was substantial at 10.36%, the year-on-year (YoY) growth was moderate at 1.2%.

 

EXPENSES: 
The company's total expenses for Q2FY24 amounted to ₹3,685 crores, showing a QoQ increase of 6.97%. However, YoY, expenses decreased by -2.33% compared to Q2FY23.

 

NET PROFIT: In Q2FY24, Britannia reported a net profit of ₹586 crores, marking a significant increase of 28.79% compared to the preceding quarter. YoY, the net profit also showed a healthy growth of 19.59% compared to the net profit of ₹490 crores in Q2FY23.

 

MARGINS: Britannia's margin in Q2FY24 stands at an impressive 13.07%, which is a noteworthy increase compared to the margin of 11.20% in the preceding quarter, Q1FY24. The margin growth YoY is also positive, rising from 11.06% in Q2FY23.

 

In conclusion, Britannia's financial performance in the second quarter of fiscal year 2024 demonstrates strong growth in revenue, net profit, and margins, especially when compared to the preceding quarter, Q1FY24. The company's ability to manage expenses effectively and maintain profitability is commendable, indicating resilience and efficient strategies in the ever-evolving market.

 

Stay tuned for more updates on upcoming financial performances.

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions